Bruker (BRKR)
(Delayed Data from NSDQ)
$63.32 USD
-0.05 (-0.08%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $63.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Company Summary
Billerica, MA-headquartered Bruker Corporation designs and manufactures proprietary life science and materials research systems and associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. Currently, Bruker employs 6,000 individuals who work at 90 locations across the globe. It has direct sales forces employed through North America, Europe, Japan, Asia Pacific and Australia.
Business Segments
The company reports through four segments:
Bruker Scientific Instruments (BSI) BioSpin: Comprised 26.9% of 2023 total revenues, up 14.6% from 2022.The division includesthe ...
Company Summary
Billerica, MA-headquartered Bruker Corporation designs and manufactures proprietary life science and materials research systems and associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. Currently, Bruker employs 6,000 individuals who work at 90 locations across the globe. It has direct sales forces employed through North America, Europe, Japan, Asia Pacific and Australia.
Business Segments
The company reports through four segments:
Bruker Scientific Instruments (BSI) BioSpin: Comprised 26.9% of 2023 total revenues, up 14.6% from 2022.The division includesthe Bruker Magnetic Resonance, Applied Industrial and Clinical, Preclinical Imaging and Service and Lifecycle Support and Integrated Data Solution Divisions. This mainly designs, manufactures and distributes enabling life science tools based on the magnetic resonance technology.
BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection) (32.4% of revenues, up 16.8%): It comprises the Bruker Life Sciences Mass Spectrometry, Bruker Microbiology and Diagnostics and Bruker Optics Divisionsand primarily designs, manufactures and distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments.
BSI NANO (31.8%, up 19.7%): The segment combines the Bruker AXS, Bruker Nano Surfaces, Bruker Nano Analytics and Bruker Metrology divisions, Consolidated Fluorescence Microscopy, Canopy Biosciences and Acuity Business Units. This mainly designs, manufactures and distributes advanced X-ray instruments to determine the characteristics of matter and the three-dimensional structure of molecules.
Bruker Energy & Supercon Technologies (BEST) (9.5% of revenues, up 18.4%): It develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and “big science” research.
General Information
Bruker Corporation
40 Manning Road
Billerica, MA 01821
Phone: 978-663-3660
Fax: 978-663-5585
Email: investor.relations@bruker.com
Industry | Instruments - Scientific |
Sector | Computer and Technology |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.63 |
Current Year EPS Consensus Estimate | 2.61 |
Estimated Long-Term EPS Growth Rate | 10.60 |
Exp Earnings Date | 11/7/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 63.37 |
52 Week High | 94.86 |
52 Week Low | 53.79 |
Beta | 1.18 |
20 Day Moving Average | 859,830.12 |
Target Price Consensus | 81.45 |
4 Week | 4.88 |
12 Week | -2.28 |
YTD | -13.76 |
4 Week | 2.45 |
12 Week | -2.24 |
YTD | -24.81 |
Shares Outstanding (millions) | 151.39 |
Market Capitalization (millions) | 9,593.87 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.32% |
Annual Dividend | $0.20 |
Payout Ratio | 0.08 |
Change in Payout Ratio | -0.01 |
Last Dividend Payout / Amount | 8/30/2024 / $0.05 |
Fundamental Ratios
P/E (F1) | 24.29 |
Trailing 12 Months | 25.45 |
PEG Ratio | 2.29 |
vs. Previous Year | 4.00% |
vs. Previous Quarter | -1.89% |
vs. Previous Year | 17.42% |
vs. Previous Quarter | 10.95% |
Price/Book | 5.10 |
Price/Cash Flow | 17.73 |
Price / Sales | 3.08 |
6/30/24 | 24.92 |
3/31/24 | 27.31 |
12/31/23 | 29.94 |
6/30/24 | 7.91 |
3/31/24 | 8.82 |
12/31/23 | 9.68 |
6/30/24 | 1.65 |
3/31/24 | 1.81 |
12/31/23 | 1.80 |
6/30/24 | 0.75 |
3/31/24 | 0.91 |
12/31/23 | 0.99 |
6/30/24 | 11.71 |
3/31/24 | 12.07 |
12/31/23 | 12.80 |
6/30/24 | 11.29 |
3/31/24 | 13.38 |
12/31/23 | 14.41 |
6/30/24 | 14.60 |
3/31/24 | 16.97 |
12/31/23 | 18.36 |
6/30/24 | 12.43 |
3/31/24 | 9.86 |
12/31/23 | 10.08 |
6/30/24 | 1.52 |
3/31/24 | 1.55 |
12/31/23 | 1.59 |
6/30/24 | 1.18 |
3/31/24 | 0.95 |
12/31/23 | 0.83 |
6/30/24 | 54.33 |
3/31/24 | 48.97 |
12/31/23 | 45.81 |